Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

INDRAPRASTHA MEDICAL Gains 19%; BSE HEALTHCARE Index Up 0.9%
Tue, 6 Aug 10:44

INDRAPRASTHA MEDICAL Gains 19%; BSE HEALTHCARE Index Up 0.9%Image source: DNY59/www.istockphoto.com

INDRAPRASTHA MEDICAL share price has zoomed 19% and is presently trading at Rs 308.6.

Meanwhile, the BSE HEALTHCARE index is at 40,432.1 (up 0.9%).

Among the top gainers in the BSE HEALTHCARE index today are ASTRAZENECA PHARMA (up 3.8%) and GLAND PHARMA (up 3.7%).

FORTIS HEALTHCARE (down 0.9%) and AJANTA PHARMA (down 0.7%) are among the top losers today.

Over the last one year, INDRAPRASTHA MEDICAL has moved up from Rs 124.8 to Rs 308.6, registering a gain of Rs 183.9 (up 147.4%).

On the other hand, the BSE HEALTHCARE index has moved up from 27,485.7 to 40,432.1, registering a gain of 47.1% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 126.5%), GRANULES INDIA (up 103.1%) and SUVEN PHARMACEUTICALS (up 102.3%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 79,212.8 (up 0.6%).

The top gainers among the BSE Sensex today are Tech Mahindra (up 2.3%) and JSW Steel (up 2.0%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.

In the meantime, NSE Nifty is at 24,176.3 (up 0.5%). Tech Mahindra and Adani Enterprises are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,782.8 to 79,212.8, registering a gain of 13,430.0 points (up 20.4%).

INDRAPRASTHA MEDICAL Financial Update...

INDRAPRASTHA MEDICAL net profit grew 46.8% YoY to Rs 448 million for the quarter ended June 2024, compared to a profit of Rs 305 million a year ago. Net sales rose 13.5% to Rs 3,479 million during the period as against Rs 3,065 million in April-June 2023.

For the year ended March 2023, INDRAPRASTHA MEDICAL reported 47.0% increase in net profit to Rs 862 million compared to net profit of Rs 586 million during FY22. Revenue of the company grew 23.7% to Rs 10,987 million during FY23.

The current Price to earnings ratio of INDRAPRASTHA MEDICAL, based on rolling 12 month earnings, stands at 20.5.


Equitymaster requests your view! Post a comment on "INDRAPRASTHA MEDICAL Gains 19%; BSE HEALTHCARE Index Up 0.9%". Click here!